ACTINIUM PHARMACEUTICALS PRESENTS EANM 2026 RESULTS REINFORCING ATNM-400'S PAN-TUMOR POTENTIAL ACROSS LUNG, COLORECTAL AND OVARIAN CANCER MODELS

Reuters · 3d ago

Please log in to view news